VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-01645
Package ID: USCOURTS-cofc-1_16-vv-01645
Petitioner: Virven Warren
Filed: 2016-12-14
Decided: 2018-06-04
Vaccine: influenza
Vaccination date: 2016-03-23
Condition: Guillain-Barre Syndrome
Outcome: compensated
Award amount USD: 110000

AI-assisted case summary:
Virven Warren, an adult, filed a petition for compensation under the National Vaccine Injury Compensation Program on December 14, 2016. He alleged that he suffered from Guillain-Barre Syndrome (GBS) as a result of receiving an influenza vaccine on or about March 23, 2016. The respondent, the Secretary of Health and Human Services, denied that the influenza immunization caused Mr. Warren's GBS or any other injury. Despite this denial, the parties filed a joint stipulation on June 4, 2018, agreeing to settle the issues and award compensation to Mr. Warren. The stipulation awarded Mr. Warren a lump sum of $110,000.00, payable by check, representing compensation for all damages. Special Master Thomas L. Gowen found the stipulation reasonable and adopted it as the decision of the Court, ordering judgment to be entered in accordance with the stipulation. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or the mechanism of causation. Petitioner counsel was Nancy Routh Meyers of Ward Black Law, and respondent counsel was Camille Michelle Collett of the United States Department of Justice.

Theory of causation field:
Virven Warren alleged Guillain-Barre Syndrome (GBS) following an influenza vaccine administered on or about March 23, 2016. The respondent denied causation. The parties reached a joint stipulation to settle the case, agreeing to an award of $110,000.00. Special Master Thomas L. Gowen adopted the stipulation as the decision of the Court. The public text does not detail the specific theory of causation, medical experts, or the mechanism of injury. The case was settled via stipulation, with petitioner counsel Nancy Routh Meyers and respondent counsel Camille Michelle Collett involved. The decision date was June 4, 2018.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-01645-0
Date issued/filed: 2018-06-29
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 06/04/2018) regarding 40 DECISION of Special Master on Stipulation. Signed by Special Master Thomas L. Gowen. (kl) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-01645-UNJ Document 41 Filed 06/29/18 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: June 4, 2018
* * * * * * * * * * * * *
VIRVEN WARREN, * UNPUBLISHED
*
Petitioner, * No. 16-1645V
*
v. * Special Master Gowen
*
SECRETARY OF HEALTH * Joint Stipulation; Influenza (“Flu”);
AND HUMAN SERVICES, * Guillain-Barre Syndrome (“GBS”).
*
Respondent. *
* * * * * * * * * * * * *
Nancy Routh Meyers, Ward Black Law, Greensboro, NC, for petitioner.
Camille Michelle Collett, United States Department of Justice, Washington, DC, for respondent.
DECISION ON STIPULATION1
On December 14, 2016, Virven Warren (“Petitioner”) filed a petition for compensation
pursuant to the National Vaccine Injury Compensation Program.2 Petitioner alleged that he
suffered from Guillain-Barre Syndrome (“GBS”) as a result of an influenza vaccine administered
on or about March 23, 2016. Petition at Preamble; Stipulation at ¶ 4.
On June 4, 2018, the parties filed a joint stipulation (“Stipulation”) in which they stated
that a decision should be entered awarding compensation to petitioner. ECF No. 39. Respondent
denies that the influenza immunization is the cause of petitioner’s alleged GBS or any other
injury or condition. Id. at ¶ 6.
1
Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this decision contains a
reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of
Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the decision
is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any information
furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or
confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed
redacted version of the decision.” Id. If neither party files a motion for redaction within 14 days, the decision
will be posted on the court’s website without any changes. Id.
2
The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012)
(Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. §
300aa.

Case 1:16-vv-01645-UNJ Document 41 Filed 06/29/18 Page 2 of 7
Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding
compensation to petitioner according to the terms of the joint stipulation attached hereto as
Appendix A.
The joint stipulation awards:
1) A lump sum of $110,000.00 in the form of a check payable to petitioner. This
amount represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a).
I find the stipulation reasonable and I adopt it as the decision of the Court in
awarding damages, on the terms set forth therein.
Accordingly, the Clerk of the Court SHALL ENTER JUDGMENT in accordance with
the terms of the parties’ stipulation.3
IT IS SO ORDERED.
s/Thomas L. Gowen
Thomas L. Gowen
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the
right to seek review.
2

Case 1:16-vv-01645-UNJ Document 41 Filed 06/29/18 Page 3 of 7

Case 1:16-vv-01645-UNJ Document 41 Filed 06/29/18 Page 4 of 7

Case 1:16-vv-01645-UNJ Document 41 Filed 06/29/18 Page 5 of 7

Case 1:16-vv-01645-UNJ Document 41 Filed 06/29/18 Page 6 of 7

Case 1:16-vv-01645-UNJ Document 41 Filed 06/29/18 Page 7 of 7